Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mometasone Furoate Nasal Spray in Seasonal Allergic Rhinitis
NCT06200766Phase 3Completed
- Sponsor
- Zheng Liu ENT
- Start
- Aug 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mometasone furoate nasal spray in seasonal allergic rhinitis (SAR), sponsored by Zheng Liu ENT. Started Aug 2023; status: completed.
02
Drugs
mometasone furoate nasal spray
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT06200766.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06200766.